Trademark Overview
On Monday, March 17, 2025, a trademark application was filed for OPTIMIZATION-BY-DESIGN with the United States Patent and Trademark Office. The USPTO has given the OPTIMIZATION-BY-DESIGN trademark a serial number of 99087625. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, November 6, 2025. This trademark is owned by Andelyn Biosciences, Inc.. The OPTIMIZATION-BY-DESIGN trademark is filed in the Pharmaceutical Products, Advertising, Business and Retail Services, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:
Product development for others relating to pharmaceuticals, biopharmaceuticals; scientific and technological consulting services, namely, research and design in the field of pharmaceutical industry; product testing and research in the field of pharmaceuticals, biopharmaceuticals; industrial research in the field of pharmaceuticals, biopharmaceuticals; pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical research and development; product development consultation; product research services, namely, providing analytical product testing, biosafety product testing and laboratory services for the production of pharmaceutical preparations for others; scientific and technical product development consulting for the pharmaceutical industry; research services in the field of pharmaceuticals; custom design and development of chemical reagents and biochemical assays; providing online non-downloadable computer software platform for users to access an i...
Business collaboration services, namely, providing a national computer-based networking web site for medical researchers to collaborate across disciplines to contract for development and manufacture of gene therapy and pharmaceutical products.
Manufacturing services for others in the field of pharmaceuticals, biopharmaceuticals, health care products and medical products; treatment of materials, namely, pharmaceutical and chemical products and their components used in the manufacture of pharmaceuticals and biopharmaceuticals; manufacture of pharmaceuticals and biopharmaceuticals to order and/or specification of others; contract manufacturing of pharmaceuticals, cells and gene therapy reagents.
Pharmaceutical preparations, biological preparations, and gene therapy products, namely, genetically engineered tissues for transplant purposes for medical or pharmaceutical purposes, namely, viral vector vaccines, and nucleic-acids delivery products for use in the treatment of genetic diseases and disorders.
